Contact us

Topical Products CDMO Companies
Contract Manufacturing Services for Transdermal Products

Your Trusted Partners for Topical and Transdermal Products Contract Manufacturing and Development

Showing 29 facilities
Laboratorio REIG JOFRE, SA (BARCELONA PLANT)
Spain

Laboratorio REIG JOFRE, SA (BARCELONA PLANT)

LABORATORIO REIG JOFRE SA

Injectable (lyo and liquid) and Liquid manufacturing facilities.

BSL (Biological Safety Level): 3, 1, 2

MARKETS: EMA (EU), PMDA (Japan), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MHRA (UK), INVIMA (Colombia), MFDS (South Korea), TGA (Australia)

REGION: Europe

BATCH SIZE: Large, Medium

USE: Human, Veterinary

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (N) Nervous system, (R) Respiratory system, (A) Digestive tract and metabolism

CONTROLLED SUBSTANCES: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

COMPLIANCE: PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), ECOVADIS, INVIMA, ISP (Chile BPM), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Sidefarma
Portugal

Sidefarma

Sidefarma SA

CMO specialized in the manufacture of small and medium size batches for pharmaceutical companies across the world in regulated markets.

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), Health Canada (Canada), DIGEMID (Peru), MHRA (UK), SFDA (Saudi Arabia), Turkish Health Authorities, EDE (UAE), TGA (Australia)

REGION: Europe

COMPLIANCE: ISO, UAE Ministry of Health & Prevention, EMA (EU GMP)

USE: Human

SERVICES: Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

BATCH SIZE: Small, Medium

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

HISTOCELL S.L. | Cell Therapy, Exosomes & Secretomes
Spain

HISTOCELL S.L. | Cell Therapy, Exosomes & Secretomes

HISTOCELL

Histocell is a Spanish CDMO that develops and manufactures cell therapies, secretomes and exosomes, as well medical devices.

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (D) Dermatologicals, (M) Musculoskeletal system, (N) Nervous system, (R) Respiratory system, (B) Blood and blood forming organs, (A) Digestive tract and metabolism

MARKETS: MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), MFDS (South Korea), CDSCO (India), TGA (Australia), EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities

BATCH SIZE: Small, Medium

COMPLIANCE: EMA (EU GMP), ISO

CATEGORY / PRODUCT: BIOLOGICS, SERVICES, FDF / DRUG PRODUCTS, COSMETICS

REGION: Europe

USE: Human, Veterinary

BSL (Biological Safety Level): 1, 2

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services

FAES FARMA | DERIO facility
Spain

FAES FARMA | DERIO facility

FAES FARMA

Developer and manufacturer of human medicinal products.

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), MFDS (South Korea), EDE (UAE), TGA (Australia)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, Roszdravnadzor (Russia GMP), ECOVADIS, TGA (Australia GMP), INVIMA, ISP (Chile BPM), French Service-Public (CIR), NMPA (China GMP), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

USE: Human

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (N) Nervous system, (R) Respiratory system, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 10,000 µg/day)

Aenova Group - Location Carugate, Italy
Italy

Aenova Group - Location Carugate, Italy

Aenova

Competence Center Semisolids and non-sterile liquids.

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

MARKETS: EMA (EU), ANVISA (Brazil), Russian Health Authorities, SFDA (Saudi Arabia)

REGION: Europe

COMPLIANCE: ISO, Roszdravnadzor (Russia GMP), SFDA (Saudi Food & Drug Authority), EMA (EU GMP)

BATCH SIZE: Large, Small, Medium

CATEGORY / PRODUCT: COSMETICS, FDF / DRUG PRODUCTS

USE: Human, Veterinary

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

AdhexPharma SAS
France

AdhexPharma SAS

AdhexPharma

CDMO for transdermal patches and oromucosal films.

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), MHRA (UK)

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, EMA (EU GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

SERVICES: Development services, Manufacturing services, Analytical / QC services

THERAPEUTIC AREAS OF EXPERTISE (ATC): (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (N) Nervous system

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Adragos Pharma | Leipzig
Germany

Adragos Pharma | Leipzig

Adragos Pharma

Non-sterile semi-solid and liquid pharmaceutical products.

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), MHRA (UK), MFDS (South Korea)

SERVICES: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

COMPLIANCE: EMA (EU GMP)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Adragos Pharma |  Athens
Greece

Adragos Pharma | Athens

Adragos Pharma

Specializes in the development of Value Added Medicines and has been recently upgraded with HPAPI capabilities.

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), ANMAT (Argentina), SFDA (Saudi Arabia), MFDS (South Korea), EDE (UAE), CDSCO (India), TGA (Australia)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), UAE Ministry of Health & Prevention, NMPA (China GMP), EMA (EU GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP), NSF

BATCH SIZE: Large, Small, Medium

USE: Human

CATEGORY / PRODUCT: SERVICES, FDF / DRUG PRODUCTS

Adragos Pharma | Livron
France

Adragos Pharma | Livron

Adragos Pharma

Manufacture of sterile liquids and suppositories. We handle more than 100 molecules, narcotics management, and analysis and stability services.

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), MHRA (UK), MFDS (South Korea), CDSCO (India), TGA (Australia)

SERVICES: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

BATCH SIZE: Large, Small, Medium

USE: Human

COMPLIANCE: EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

PHARMALOOP S.L. - a Salvat Company
Spain

PHARMALOOP S.L. - a Salvat Company

Laboratorios Salvat

Fully integrated CDMO solutions for Blow-Fill-Seal (BFS), sterile multidose, non-sterile multi-dose, sachets, capsules and tablets.

MARKETS: EMA (EU), FDA (USA)

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, EMA (EU GMP)

BATCH SIZE: Large, Small, Medium

USE: Human

BSL (Biological Safety Level): 1

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

THERAPEUTIC AREAS OF EXPERTISE (ATC): (S) Sensory organs, (V01) Allergens

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, PARTICLE ENGINEERING

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 10,000 µg/day)

Limited view

CHEMICAL-SYNTHETIC manufacturing site

MAI network supplier

Solutions for non Viral Delivery programs

Location available after registration

Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

EU-GMP-certified CMO based in Martin, Slovakia. The company provides manufacturing and packaging servicesfor sterile pharm. products and solid oral dosage forms

Location available after registration

More facilities on the network

Register to unlock the full catalog with contact details and locations.

+16 more facilities

Create free account

Topical, mucosal, and transdermal products, including creams, ointments, gels, lotions, patches, and sprays, are essential for localized and systemic drug delivery. These dosage forms require specialized formulation and manufacturing to ensure stability, absorption, and efficacy. Contract Development and Manufacturing Organizations (CDMOs) for topical and transdermal products offer comprehensive services from formulation development to large-scale manufacturing while maintaining strict adherence to quality and regulatory standards.

How to Choose a Contract Manufacturer for Topical and Transdermal Pharmaceutical Products

Selecting the right CDMO for topical and transdermal products is critical to ensure optimal drug delivery, product stability, and regulatory compliance. Choose a partner with expertise in various dosage forms such as creams, gels, lotions, transdermal patches, and mucosal sprays.

Evaluate their knowledge in skin permeation, viscosity control, and bioavailability enhancement. The topical products manufacturer should have a robust quality assurance system and hold certifications from global regulatory agencies like EMA, FDA, and WHO. Make sure they offer scalability for small-batch production as well as high-volume commercial manufacturing.

Key Services Offered by Topical Products Manufacturing Companies

Formulation Development: Expertise in developing stable and effective formulations for creams, ointments, gels, transdermal patches, sprays, and mucosal products.

Manufacturing: High-precision production for a wide variety of topical and transdermal products, utilizing advanced technologies to ensure consistency and efficacy.

Regulatory Support: Assistance with regulatory filings and compliance, facilitating smooth approval processes for global markets.

Packaging Solutions: Customized primary and secondary packaging options such as tubes, bottles, unit-dose sachets, and patch packaging to preserve product integrity and ensure ease of use.

Analytical Testing: Comprehensive testing for stability, skin permeation, homogeneity, and efficacy at every stage of production.

Advantages of Partnering with Topical and Transdermal Products CDMOs

Regulatory Expertise: Extensive experience navigating global regulatory landscapes to ensure market approval for all topical, mucosal, and transdermal products.

State-of-the-Art Facilities: Cutting-edge technologies for precision manufacturing of topical and transdermal products.

Flexibility and Scalability: From clinical trial batches to large-scale commercial production, topical CDMOs provide tailored solutions to meet your evolving needs.

Innovation and Customization: Expertise in skin permeation enhancement, viscosity optimization, and advanced drug delivery systems ensures patient-friendly and effective formulations.

Cost Efficiency: Streamlined processes and technological advancements enable high-quality products at competitive prices.

Topical and Transdermal CDMO Companies

Some of the most trusted topical CDMO companies include:

  • FAES FARMA: Developer and manufacturer of human medicinal products. [See CDMO profile]
  • Pharmaloop (a Salvat company): Fully integrated CDMO solutions for topical products. [See CDMO profile]
  • Reig Jofre: Topical liquids manufacturing facilities. [See CDMO profile]
  • Sidefarma: Specialized in small and medium batch manufacturing: topical, oral liquids, semisolids, and oral solids / OSD. [See CDMO profile]
  • Darnytsia Kyiv: Advanced facilities, strict quality control, and expert teams. Manufacturing topical, oral liquids and semisolids, oral solids / OSD. [See CDMO profile]
  • HISTOCELL S.L: Developer of cell therapies (iPSCs, MSCs, secretomes, exosomes), medical devices, and dermocosmetics. [See CDMO profile]
  • I+Med: Developer of new drug products with controlled-release technologies, including implants, oral liquids, semisolids, and oral solids. [See CDMO profile]
  • Aenova Group: Competence center for semisolids, non-sterile liquids, oral liquids, and topical/mucosal products. [See CDMO profile]
  • Adragos Pharma: Manufacturer of semi-solid and non-sterile liquid pharmaceuticals for topical, mucosal, and transdermal applications. [See CDMO profile]
  • AdhexPharma SAS: Specialized in transdermal patches and oromucosal films. [See CDMO profile]
  • Basic Pharma: Tailored CDMO services with full quality compliance; topical, oral solids / OSD, sterile forms. [See CDMO profile]
  • Ascendia Pharmaceutical Solutions: GMP-certified CDMO providing advanced sterile and non-sterile pharmaceutical manufacturing, formulation development, and comprehensive analytical testing services. [See CDMO profile]
  • Content Group: Tubilux Pharma manufacturing site, serving as registered office and production facility, supporting pharmaceutical manufacturing operations. [See CDMO profile]

Related Information

Let MAI CDMO Help You Find the Right Topical and Transdermal Products Manufacturing Partner

Finding the right CDMO for topical and transdermal products can be challenging, but MAI CDMO Network simplifies the process. We connect you with trusted manufacturers specializing in high-quality and innovative solutions for topical, mucosal, and transdermal formulations.

Our experienced team works closely with you to ensure your project goals align with the strengths of leading topical CDMOs, supporting your journey from development to market.

Contact us today to explore the best topical and transdermal contract manufacturers and start your pharmaceutical project with a reliable partner.